Answers are grounded in this paper and cite their sources.
The coreceptor discoveries revealed new insights into host and viral factors influencing HIV transmission and disease. The HIV/coreceptor interaction has become a major target for the development of novel antiviral strategies to treat and prevent HIV infection. The first CCR5-based entry inhibitor has been recently approved. New drugs that promote CCR5 and CXCR4 internalization, independent of cellular signaling, might provide clinical benefits with minimum side effects.
No takes yet. Share an insight, caveat, or question.
Ghalib Alkhatib (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: